Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

371 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-20

Study Completion Date

2023-08-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Dynamics of Organ Damage and Immune Exhaustion During Sepsis

NCT06817408

Sepsis

RECRUITING

Metabolomic Alterations in the Vascular Compartment in Patients With Sepsis

NCT03655899

Endothelial Dysfunction

TERMINATED

Function of Circulating Exosomes in Sepsis-induced Immunosuppression

NCT04979767

Sepsis Septic Shock Sepsis Syndrome +3 more

UNKNOWN

ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis

NCT04522310

Covid19

COMPLETED

Effect of APC and Epo on the Inflammatory Response During Sepsis

NCT00229034

Sepsis Systemic Inflammation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Extracorporeal Membrane Oxygenation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ECMO

No intervention. Blood specimen collection.

Blood specimen collection

Intervention Type OTHER

Control

No intervention. Blood specimen collection.

Blood specimen collection

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood specimen collection

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Greater than or equal to 18 years of age
* Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

* Greater than 18 years of age
* Without any known cardiovascular, lung, or autoimmune disease.

Exclusion Criteria

* Subject is less than 18 years of age
* Known prisoner

Control Subjects:

* Less than or equal to 18 years of age
* Known cardiovascular, lung, or autoimmune disease

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No